ARK Genomic Revolution ETF (ARKG) Stock
Financial Services · Asset Management · US
$43.54
+1.47%
Last updated Jul 6, 2026 20:15 UTC
ARKG Key Statistics
Market Cap$1.35B
P/E (TTM)—
P/S (TTM)—
P/B (TTM)—
Revenue (TTM)$0.00
EPS (TTM)—
Dividend Yield—
ROE (TTM)—
Net Margin—
Gross Margin—
52W High$43.91
52W Low$22.73
Analyst View—
Price Target—
Employees—
Volume3,774,588
About ARK Genomic Revolution ETF
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.
See ARKG live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ARKG in Terminal See plans